ARCHIVES

Action Plan Steering committee votes 13-0 To Return $14 Million To NCI for Research

This article is from The Cancer Letter archive.

Vol. 22 No. 44 | November 15, 1996

Download PDF Visit The Full Archive

Related Articles

Advisors OK Planning Grants In Breast Cancer For Cancer Centers

July 9, 1993

Workers Ignorant Of Benzidine Risk, Union tells Congress

April 3, 1987

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

September 30, 2011

NCI Cooperative Group Clinical Trials Approved

August 27, 2010

Funding opportunities listed.

March 26, 2004

FDA Oncology Division To Develop Papers On Expectations for New Drugs

August 2, 1996